Eric Kmiec

CSO · CorriXR Therapeutics · company speakers →

Dr. Kmiec is a pioneering molecular biologist and a leading authority in gene editing and genetic therapies. He is the Founder and Executive Director of ChristianaCare’s Gene Editing Institute, where he has spearheaded groundbreaking research in CRISPR-based technologies, particularly targeting inherited disorders and cancer. Dr. Kmiec is also the Founder and CEO of CorriXR Therapeutics advacing in vivo CRISPR directed gene editing for the treatment of squamous cell carcinoma. He holds academic appointments at the University of Delaware and the Wistar Institute.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

In Vivo Cell Engineering & Gene Editing Summit

28 July 2026 Boston, United States “In Vivo Gene Editing for the Treatment of Squamous Cell Carcinomas, a Direct Platform Approach”

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →